A 48-Week, Multicentre, Multinational, Randomized, Double-Blind, 2-Arm Parallel Group, Comparing the Efficacy of Foster for Maintenance and Reliever Versus Fixed-Dose Foster for Maintenance Plus Salbutamol as Reliever in Asthmatics > or = 18 Years of Age.
Phase of Trial: Phase III
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Salbutamol
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors Chiesi Farmaceutici
- 04 Apr 2017 Last checked against ClinicalTrials.gov record.
- 21 Apr 2012 Planned number of patients changed from 2404 to 2482 as reported by European Clinical Trials Database.
- 21 Apr 2012 Additional trial locations added as reported by European Clinical Trials Database.